medigraphic.com

2017, Número 2

<< Anterior Siguiente >>

Rev Hosp Jua Mex 2017; 84 (2)


Síndrome de vena cava superior asociado a neoplasia. Consideraciones multidisciplinarias y tratamiento

López-Riverol O, Camacho-Limas CP, Gerson-Cwilich R

Idioma: Español
Referencias bibliográficas: 31
Paginas: 77-82
Archivo PDF: 166.68 Kb.


RESUMEN

El síndrome de vena cava superior (SVCS) se presenta por una obstrucción de la vena cava superior que provoca un incremento de la presión venosa en vasos sanguíneos colaterales y conforme esta obstrucción avanza, se desarrolla un flujo sanguíneo colateral. Las neoplasias ocasionan cerca de 90% de los casos. Se recomienda realizar una historia clínica con atención en antecedentes de procedimientos invasivos, neoplasia y en la duración de los síntomas. La presentación clínica va a depender de la evolución de la neoplasia subyacente y por lo general encontramos edema de cara, cuello, tórax, extremidades superiores y red venosa colateral, seguido de disnea. El tratamiento y pronóstico depende de la histología, etapificación y tratamientos previos. En esta revisión nos enfocaremos en la etiología, fisiopatogenia, diagnóstico y tratamiento del SVCS asociado a neoplasia.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med 2007; 356(18): 1862-9.

  2. Eren S, Karaman A, Okur A. The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT. Eur J Radiol 2006; 59(1): 93-103.

  3. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006; 85(1): 37-42.

  4. Kinnard E. Superior vena cava syndrome in the cancer patient: a case study. J Adv Pract Oncol 2012; 3(6): 385-7.

  5. Lepper PM, Ott SR, Hoppe H, Schumann C, Stammberger U, Bugalho A, et al. Superior vena cava syndrome in thoracic malignancies. Respir Care 2011; 56(5): 653-66.

  6. Hohloch K, Bertram N, Trumper L, Beissbarth T, Griesinger F. Superior vena cava syndrome caused by a malignant tumor: a retrospective single center analysis of 124 cases. J Cancer Res Clin Oncol 2014; 140(12): 1764-66.

  7. Wakeda H, Hamasuna R, Asada Y, Kamoto T. Superior vena cava syndrome due to metastasis from urothelial cancer: a case report and literature review. Urol Ann 2013; 5(4): 291-3.

  8. Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am 2010; 24(3): 501-13.

  9. Chen JC, Bongard F, Klein SR. A contemporary perspective on superior vena cava syndrome. Am J Surg 1990; 160(2): 207-11.

  10. Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DW. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. SpringerPlus 2016; 5: 229.

  11. Lonardi F, Gioga G, Agus G, Coeli M, Campostrini F. Double-flash, large-fraction radiation therapy as palliative treatment of malignant superior vena cava syndrome in the elderly. Support Care Cancer 2002; 10(2): 156-60.

  12. Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome-a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3(8): 811-4.

  13. Kishi K, Sonomura T, Mitsuzane K, Nishida N, Yang RJ, Sato M, et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993; 189(2): 531-5.

  14. Parish JM, Marschke RF Jr, Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc 1981; 56(7): 407-13.

  15. Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importance of collateral vessels. AJR Am J Roentgenol 1993; 161(3): 539-42.

  16. Rachapalli V, Boucher LM. Superior vena cava syndrome: role of the interventionalist. Can Assoc Radiol J 2014; 65(2): 168-76.

  17. Cheng S. Superior vena cava syndrome: a contemporary review of a historic disease. Cardiol Rev 2009; 17(1): 16-23.

  18. Lee D, Moon SM, Kim D, Kim J, Chang H, Yang B, et al. Lung cancer with superior vena cava syndrome diagnosed by intravascular biopsy using EBUS-TBNA. Respir Med Case Rep 2016; 19: 177-180.

  19. Davenport D, Ferree C, Blake D, Raben M. Radiation therapy in the treatment of superior vena caval obstruction. Cancer 1978; 42(6): 2600-3.

  20. Watkinson AF, Yeow TN, Fraser C. Endovascular stenting to treat obstruction of the superior vena cava. BMJ 2008; 336(7658): 1434-7.

  21. Armstrong BA, Perez CA, Simpson JR, Hederman MA. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987; 13(4): 531-9.

  22. Chan RH, Dar AR, Yu E, Stitt LW, Whiston F, Truong P, et al. Superior vena cava obstruction in small-cell lung cancer. Int J Radiat Oncol Biol Phys 1997; 38(3): 513-20.

  23. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001; (4): CD001316.

  24. Din OS, Harden SV, Hudson E, Mohammed N, Pemberton LS, Lester JF, et al. Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centers. Radiother Oncol 2013; 109(1): 8-12.

  25. Robinson C, Stephans K, Reddy C, Djemil T, Videtic G. Stereotactic body radiotherapy (SBRT) for radiographically diagnosed primary lung cancer without histologic confirmation. Int J Radiat Oncol Biol Phys 2009; 75(3): S453-4.

  26. Maleux G, Gillardin P, Fieuws S, Heye S, Vaninbroukx J, Nackaerts K. Large-bore nitinol stents for malignant superior vena cava syndrome: factors influencing outcome. AJR Am J Roentgenol 2013; 201(3): 667-74.

  27. Gwon DI, Ko GY, Kim JH, Shin JH, Yoon HK, Sung KB. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology 2013; 266(3): 979-87.

  28. Rachapalli V, Boucher LM. Superior vena cava syndrome: role of the interventionalist. Can Assoc Radiol J 2014; 65(2): 168-76.

  29. Rojas G, Gerson R, Cervantes J, Lázaro M, Ponte R, Enríquez E, et al. Empleo del filtro de Greenfield en pacientes con cáncer, trombosis venosa profunda y/o tromboembolismo pulmonar. Cir Cir 1994; 61(1): 20-4.

  30. Magnan PE, Thomas P, Guidicelli R, Fuentes P, Brancherau A. Surgical reconstruction of the superior vena cava. Cardiovasc Surg 1994; 2(5): 598-604.

  31. Schraufnagel DE, Hill R, Leech JA, Pare JAP. Superior vena caval obstruction: is it a medical emergency? Am J Med 1981; 70(6): 1169-74.




2020     |     www.medigraphic.com